Autophagic pathways as new targets for cancer drug development

Keyphrases

• New Targets 100%
• Autophagy 100%
• Autophagic Pathway 100%
• Oncology Drug Development 100%
• In Cancer 60%
• Evolutionarily Conserved 40%
• Autophagy-related Genes 40%
• Protein Kinase 20%
• Tumor Progression 20%
• Mammalian Target of Rapamycin (mTOR) 20%
• B-cell Lymphoma 2 (Bcl-2) 20%
• Signaling Network 20%
• Drug Discovery 20%
• Antitumor Agents 20%
• Digestion Method 20%
• Tumor Suppression 20%
• Beclin-1 20%
• Autophagic 20%
• Pathological Process 20%
• Cancer Therapeutics 20%
• Autophagosome Formation 20%
• Janus 20%
• Damaged Organelles 20%
• Long-lived Proteins 20%
• Protein Organelle 20%
• Autophagic Signaling 20%
• Modulating Agent 20%
• Class III PI3K 20%
• Self-digestion 20%
• Class I PI3K 20%
• UVRAG 20%
• Anticancer Strategy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Cancer Drug Development 100%
• Drug Discovery 20%
• Protein Kinases 20%
• Tumor Growth 20%
• Protein P53 20%
• Anticarcinogen 20%
• Cancer Inhibition 20%
• Beclin 1 20%